Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the ...(ter principally associated with th...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year
Date:11/10/2008
ter, principally
associated with the release of valuation allowances on foreign tax
credit carryforwards and the recognition of certain previously
unrecognized tax benefits associated with recently completed tax
audits.
'/>"/>
| SOURCE Hill-Rom Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
2. Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results
3. Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update
4. BMP Sunstone Reports Third Quarter 2008 Financial Results
5. Endocare Reports Financial Results for Third Quarter 2008
6. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
7. Isis Reports Financial Results and Highlights for Third Quarter of 2008
8. OncoGenex Reports Third Quarter Financial Results
9. American Oriental Bioengineering Reports Third Quarter 2008 Financial Results
10. AutoImmune Inc. Reports 2008 Third Quarter Financial Results
11. Dendreon Reports Third Quarter 2008 Financial Results
Post Your Comments:
Breaking Biology Technology:Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 2Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 3Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit 2Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit 3Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit 4Reportlinker Adds Pharmacodynamic Assays 2Reportlinker Adds Pharmacodynamic Assays 3Reportlinker Adds Pharmacodynamic Assays 4The Pittsburgh Life Sciences Greenhouse Announces Additions to Nationally Recognized Executive Program 2The Pittsburgh Life Sciences Greenhouse Announces Additions to Nationally Recognized Executive Program 3
[0] Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas[0] Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit[0] Reportlinker Adds Pharmacodynamic Assays[0] The Pittsburgh Life Sciences Greenhouse Announces Additions to Nationally Recognized Executive Program
Other Biology Technology:Breakthrough in spinal injury treatment 2Gen-Probe to Webcast Presentation at the UBS Global Life Sciences Conference 2
Breaking Biology News(10 mins):MSU research may lead to new ways to control honeybee parasite 2Germany starts its part in the International Cancer Genome Project 2Germany starts its part in the International Cancer Genome Project 3Germany starts its part in the International Cancer Genome Project 4Study confirms association between tobacco smoke and behavioral problems in children 2LifeSpan Treadmill Awarded BEST TREADMILL by Health Magazine 52317 1LifeSpan Treadmill Awarded BEST TREADMILL by Health Magazine 52317 2Studies Affirm Value of Healthy Lifestyle 52315 1Studies Affirm Value of Healthy Lifestyle 52315 2Studies Affirm Value of Healthy Lifestyle 52315 3Michigan Chamber of Commerce Raises Concerns With Flawed Federal Health Care Reform Proposal Rushed Timeline 52310 1Michigan Chamber of Commerce Raises Concerns With Flawed Federal Health Care Reform Proposal Rushed Timeline 52310 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |